Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV
Clinical trial NCT02671500 · COMPLETED
Trial details
- NCT number
- NCT02671500
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-19
- Primary completion
- 2018-01-05
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.